Roxadustat: all 61 studies that test it
Page 1 of 1. Open to participants first (6), then studies with results posted, then the rest; newest registration first within each.
- A Study to Investigate the Efficacy and Safety of Roxadustat (FG-4592) for Treating Anemia in Participants With Myelodysplastic Syndromes (MDS)Not yet recruitingNCT07722988Phase 3
- Hypoxia-inducible Factor Prolyl Hydroxylase Inhibitors on Sarcopenia in Hemodialysis PatientsNot yet recruitingNCT07162090Phase 4
- Roxadustat for Bone and Neuropsychiatric Aspects in Hemodialysis PatientsRecruitingNCT06917950Phase 1/2
- Roxadustat's Effect on Heart, Nutrition, and Inflammation in Hemodialysis PatientsRecruitingNCT06903559Phase 1/2
- Roxadustat Combined With Luspatercept Versus Luspatercept Monotherapy in the Treatment of Refractory MDS-RSNot yet recruitingNCT06006949Phase 4
- The Effect of Roxadustat on Renal Oxygenation in Diabetes NephropathyNot yet recruitingNCT05810311Phase 2
- A Study to Investigate the Effect of Roxadustat Versus Recombinant Human Erythropoietin (rHuEPO) on Oral Iron Absorption in Chinese Patients With Anemia of Chronic Kidney Disease (CKD)CompletedNCT04655027Phase 4Results posted
- Study of Roxadustat Conversion in Participants Receiving Stable ESA or as Initial Anemia Treatment in Hemodialysis ParticipantsCompletedNCT04484857Phase 3Results posted
- Study of Roxadustat Conversion in Participants Receiving Stable Erythropoiesis-Stimulating Agent (ESA) or as Initial Anemia Treatment in Chronic Dialysis ParticipantsCompletedNCT04410198Phase 3Results posted
- Evaluation of Efficacy and Safety of Roxadustat for the Treatment of Chemotherapy Induced AnemiaCompletedNCT04076943Phase 2Results posted
- Efficacy and Safety of Roxadustat for Treatment of Anemia in Participants With Lower Risk Myelodysplastic Syndrome With Low Red Blood Cell Transfusion BurdenTerminatedNCT03263091Phase 3Results posted
- Roxadustat in the Treatment of Anemia in End Stage Renal Disease (ESRD) Patients on Stable DialysisCompletedNCT02278341Phase 3Results posted
- Study to Evaluate the Efficacy and Safety of Roxadustat in the Treatment of Anemia in Participants With ESRD on Stable DialysisCompletedNCT02273726Phase 3Results posted
- Safety and Efficacy Study of Roxadustat to Treat Anemia in Patients With Chronic Kidney Disease, on Dialysis.CompletedNCT02174731Phase 3Results posted
- Safety and Efficacy Study of Roxadustat to Treat Anemia in Patients With Chronic Kidney Disease (CKD), Not on DialysisCompletedNCT02174627Phase 3Results posted
- Safety and Efficacy Study of Roxadustat (FG-4592) for the Treatment of Anemia in End-Stage Renal Disease (ESRD) Newly Initiated Dialysis ParticipantsCompletedNCT02052310Phase 3Results posted
- Roxadustat in the Treatment of Anemia in Chronic Kidney Disease (CKD) Patients, Not on Dialysis, in Comparison to Darbepoetin AlfaCompletedNCT02021318Phase 3Results posted
- Roxadustat in the Treatment of Anemia in Chronic Kidney Disease Patients Not Requiring DialysisCompletedNCT01887600Phase 3Results posted
- A Study of Roxadustat for the Treatment of Anemia in Participants With Chronic Kidney Disease and Not Receiving DialysisCompletedNCT01750190Phase 3Results posted
- Open-Label Extension Study for the Long-Term Efficacy and Safety of Roxadustat in Participants With Dialysis and Non-Dialysis Chronic Kidney DiseaseCompletedNCT01630889Phase 2Results posted
- Study of Roxadustat in Non-Dialysis Chronic Kidney Disease Participants With AnemiaCompletedNCT01244763Phase 2Results posted
- Study of Roxadustat (FG-4592) in Participants With End-Stage Renal Disease Receiving Maintenance HemodialysisCompletedNCT01147666Phase 2Results posted
- Phase 2 Study of Roxadustat in Participants With Anemia and Chronic Kidney Disease Not Requiring DialysisCompletedNCT00761657Phase 2Results posted
- Roxadustat Versus Erythropoietin for Anaemia Treatment in Diabetic NephropathyCompletedNCT07786168Not applicable
- Study of Roxadustat's Effect on Anemia in Patients With Diabetic Kidney DiseaseCompletedNCT07359027Phase 4
- Effect of Perioperative Roxadustat in Elective Lumbar Interbody Fusion Surgery.Active, not recruitingNCT06772272Phase 3
- Effect of Low Doses of Hypoxia-inducible Factor- Prolyl Hydroxylase Enzyme Inhibitor Plus Iron in the Treatment of Anemia in Dialysis-dependent Chronic Kidney Disease PatientsCompletedNCT06115421Phase 4
- A Study of Roxadustat to Treat Anemia in Children and Teenagers With Chronic Kidney DiseaseActive, not recruitingNCT05970172Phase 3
- Study of the Safety and Efficacy of Roxadustat in the Treatment of Heart Failure With Chronic Kidney Disease and AnemiaStatus unknownNCT05691257Phase 4
- A Study to Evaluate the Efficacy and Safety of Roxadustat for the Treatment of Anemia in Participants Receiving Chemotherapy Treatment for Non-Myeloid MalignanciesCompletedNCT05301517Phase 3
- Roxadustat Combined With Sacubitril Valsartan Sodium Tablets in the Treatment of Cardiorenal Anemia SyndromeStatus unknownNCT05053893Not applicable
- Study of Roxadustat for Reducing the Incidence of Acute Kidney Injury After Coronary Artery Bypass GraftingTerminatedNCT05010460Phase 2
- Investigating the Efficacy and Safety of Roxadustat (FG-4592) for Treatment of Anemia in Pediatric Patients With CKDStatus unknownNCT04925011Phase 3
- Study of Roxadustat in the Treatment of Acute Myocardial InfarctionStatus unknownNCT04803864Phase 2
- Investigating the Efficacy, Safety and PK of Roxadustat (FG-4592) for Treatment of Anemia in Pediatric Patients With CKDWithdrawnNCT04621331Phase 3
- Different Doses of Roxadustat Treatment for Anemia in Peritoneal Dialysis PatientsCompletedNCT04454879Phase 4
- Evaluate the Efficacy and Safety of Multiple Roxadustat Dosing Regimens for the Treatment of Anemia in Dialysis Participants With Chronic Kidney DiseaseCompletedNCT04059913Phase 4
- A Study to Assess the Relative Bioavailability of Roxadustat Following a Single Dose of Pediatric Azo Dye-free Tablet Formulation and Pediatric Azo Dye-free Mini-tablet Formulation Compared to a Single Dose of Azo Dye-containing Tablet Formulation in Healthy Adult SubjectsCompletedNCT03960489Phase 1
- Efficacy and Safety of FG-4592 for Treatment of Anemia in Participants With Lower Risk Myelodysplastic Syndrome (MDS)CompletedNCT03303066Phase 2/3
- A Study of Intermittent Oral Dosing of ASP1517 in Non-Dialysis Chronic Kidney Disease Patients With AnemiaCompletedNCT02988973Phase 3
- A Phase 1 Study of Roxadustat in Subjects With Different Degrees of Renal FunctionCompletedNCT02965040Phase 1
- A Study of Intermittent Oral Dosing of ASP1517 in ESA-untreated Chronic Kidney Disease Patients With AnemiaCompletedNCT02964936Phase 3
- A Study of Intermittent Oral Dosing of ASP1517 in Hemodialysis Chronic Kidney Disease Patients With AnemiaCompletedNCT02952092Phase 3
- A Drug Interaction Study to Evaluate the Pharmacokinetics of ASP1517 and Lanthanum Carbonate HydrateCompletedNCT02952040Phase 1
- A Food Effect Study to Evaluate the Pharmacokinetics of ASP1517CompletedNCT02805374Phase 1
- A Study of Intermittent Oral Dosing of ASP1517 in Peritoneal Dialysis Chronic Kidney Disease Patients With AnemiaCompletedNCT02780726Phase 3
- A Study of Intermittent Oral Dosing of ASP1517 in Erythropoieses Stimulating Agent (ESA)-Naive Hemodialysis Chronic Kidney Disease Patients With AnemiaCompletedNCT02780141Phase 3
- A Long Term Study of Intermittent Oral Dosing of ASP1517 in Hemodialysis Chronic Kidney Disease Patients With Anemia Converted From Erythropoieses Stimulating Agent (ESA) TreatmentCompletedNCT02779764Phase 3
- Pharmacokinetic Study of ASP1517 With Kremezin®CompletedNCT02693613Phase 1
- FG-4592 for Treatment of Anemia in Subjects With Chronic Kidney Disease Not on DialysisCompletedNCT02652819Phase 3
- FG-4592 for Treatment of Anemia in Subjects With Chronic Kidney DiseaseCompletedNCT02652806Phase 3
- A Study to Evaluate the Effects of Multiple Doses of FG-4592 on the Exposure, Safety and Tolerability and Effect of Warfarin in Healthy SubjectsCompletedNCT02252731Phase 1
- A Study to Evaluate the Dose-proportionality and Effects of FG-4592 in Healthy Young and Elderly Male and Female SubjectsCompletedNCT02161796Phase 1
- A Study to Investigate the Exposure and Safety and Tolerability of a Single Dose of FG-4592 in Subjects With Moderately Diminished Liver Function Compared to Those With Normal Liver FunctionCompletedNCT02161224Phase 1
- ASP1517 Phase 2 Clinical Trial - Double-Blind Study of ASP1517 for the Treatment of Anemia in Chronic Kidney Disease Patients Not on Dialysis-CompletedNCT01964196Phase 2
- A Study to Investigate the Effect of ASP1517 After Intermittent Oral Dosing in Dialysis Chronic Kidney Disease Patients With Anemia Compared With Darbepoetin as a Reference DrugCompletedNCT01888445Phase 2
- Study of FG-4592 in Subjects With Chronic Kidney Disease in ChinaCompletedNCT01599507Phase 2
- Study of FG-4592 in Subjects With End-Stage Renal Disease Receiving Maintenance Hemodialysis in ChinaCompletedNCT01596855Phase 2
- Study to Investigate the Interaction Between FG-4592 and Rosiglitazone in Healthy Adult SubjectsCompletedNCT01376063Phase 1
- ASP1517 Pharmacokinetics Study in Anemia Patients on HemodialysisCompletedNCT01083888Phase 1
- Safety, Tolerability and Pharmacokinetic Study of ASP1517 in Healthy Non-elderly Male VolunteersCompletedNCT00978198Phase 1